Cardiology Critical Care

GO-FAR Score for Post-CPR Survival

Predicts neurologically intact survival to hospital discharge after in-hospital CPR. Assists goals-of-care discussions.

Age*

Neurologically intact or with minimal deficit at admission*

Major trauma at current admission*

Acute stroke at current admission*

Metastatic or locally invasive cancer*

Septicaemia at current admission*

Hepatic insufficiency (cirrhosis or hepatic failure)*

Admitted from nursing home or long-term care facility*

Hypotension (SBP < 90 mmHg) within 4 hours before arrest*

Renal insufficiency or dialysis*

Respiratory insufficiency (not due to the arrest)*

Pneumonia at current admission*

Non-cardiac cause of arrest (metabolic, respiratory, etc.)*

Haematologic or oncologic diagnosis*

Diabetes mellitus*

Score interpretation

Good Survival Chance (>15%) 14–30

GO-FAR ≥ 14: >15% chance of neurologically intact survival to discharge.

→ CPR/resuscitation indicated. Full resuscitation effort appropriate.

Moderate Survival Chance (5–15%) 0–13

GO-FAR 0–13: 5–15% chance of neurologically intact survival.

→ Discuss resuscitation preferences with patient/family. Goals-of-care conversation warranted.

Low Survival Chance (1–5%) -14–-1

GO-FAR −1 to −14: 1–5% chance of neurologically intact survival.

→ Honest goals-of-care discussion. Resuscitation may be futile. Consider comfort-focused care.

Very Low Survival Chance (<1%) -60–-15

GO-FAR < −14: < 1% chance of neurologically intact survival.

→ Resuscitation very unlikely to benefit. Strongly recommend goals-of-care discussion and comfort-focused approach.

Interpretation bands for the GO-FAR. Apply clinical judgement and local guidance.

Ebell MH et al. The Good Outcome Following Attempted Resuscitation (GO-FAR) Score to Predict Neurologically Intact Survival After In-Hospital Cardiopulmonary Resuscitation. JAMA Intern Med. 2013;173(20):1872-1878.

Curated clinical cross-links plus same-class fallbacks.

Calculators

Drugs

Pathways

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.